CWP
DGX icon

Clark Wealth Partners’s Quest Diagnostics DGX Stock Holding History

Clark Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6K Hold
17
– – ﹤0.01% 356
2026
Q1 		$3.33K Buy
17
+9
+113% +$1.75K ﹤0.01% 398
2025
Q4 		$1.39K Hold
8
– – ﹤0.01% 460
2025
Q3 		$1.39K Buy
8
+2
+33% +$355 ﹤0.01% 460
2025
Q2 		$1.08K Hold
6
– – ﹤0.01% 427
2025
Q1 		$1.01K Buy
+6
New +$986 ﹤0.01% 437

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Clark Wealth Partners's DGX Position: Q2 2026 in Review

Clark Wealth Partners held its Quest Diagnostics (DGX) position steady in Q2 2026 at 17 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Clark Wealth Partners first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,046 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Clark Wealth Partners held 17 shares of Quest Diagnostics worth $3.6K as of Q2 2026.
  • Clark Wealth Partners left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #356 holding.
  • Clark Wealth Partners first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.